Deferred Tax Assets, Net of Valuation Allowance of Inmune Bio, Inc. from 30 Jun 2024 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Inmune Bio, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 30 Jun 2024 to 30 Sep 2024.
  • Inmune Bio, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 30 Sep 2024 was $545,000.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Inmune Bio, Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $545,000 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $590,000 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.